"tras-TOOZ-ue-mab DER-ux-TEE-kan"
Enhertu
Trastuzumab deruxtecan is used to treat certain types of cancer (such as breast cancer, lung cancer, stomach cancer, esophageal cancer, certain other solid tumors). This medication is used to treat tumors which are involved with the HER2 protein.
This medication is called a monoclonal antibody and topoisomerase inhibitor conjugate. Trastuzumab deruxtecan works by attaching to the HER2 cancer cells and blocking them from dividing and growing.
Read the Medication Guide provided by your pharmacist before you start using trastuzumab deruxtecan and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
This medication is given by slow injection into a vein by a health care professional. It is given as directed by your doctor, usually once every 3 weeks. Your first infusion will be given over at least 90 minutes.
The dosage, the speed of your injection, and the length of time you receive trastuzumab deruxtecan are based on your body weight, medical condition, and response to treatment.
To get the most benefit from this medication, do not miss any doses. To help you remember, mark the days on the calendar when you need to receive the medication.
Copyright © 2025 TraceGains, Inc. All rights reserved.
RxAnswers™ is a copyrighted combined product from TraceGains and First DataBank, Inc.
Drug information is selected from data included with permission and copyrighted by First DataBank, Inc. This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional. Always seek the advice of your healthcare professional if you have any questions about this product or your medical condition. This information is not intended as individual medical advice and does not substitute for the knowledge and judgment of your healthcare professional. This information does not contain any assurances that this product is safe, effective or appropriate for you.
This information is intended only for residents of the United States. Products sold under the same brand names in other countries may contain different ingredients.
Learn more about First DataBank
There are some limitations on the information provided in “Nutrient Interactions.” Do NOT rely solely on the information in this article. Please read the disclaimer.
Learn more about TraceGains, the company.
TraceGains and/or its suppliers make no warranties or representations as to the accuracy or completeness of this content herein or that of any organization referred or linked to within this content and will not be liable for any damages arising out of your access to or use of any information found herein or that of any organization referred to within this content.
Information expires December 2025.